The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sidney, J.
Right arrow Articles by Sette, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sidney, J.
Right arrow Articles by Sette, A.

The Journal of Immunology, Vol 152, Issue 9 4516-4525, Copyright © 1994 by American Association of Immunologists


ARTICLES

Definition of a DQ3.1-specific binding motif

J Sidney, C Oseroff, MF del Guercio, S Southwood, JI Krieger, GY Ishioka, K Sakaguchi, E Appella and A Sette
Cytel, San Diego, CA 92121.

A quantitative peptide binding assay using purified DQA1*0301/DQB1*0301 (DQ3.1) molecules was developed and validated by examining the correlation between the data obtained in the binding assay with those obtained in inhibition of Ag presentation assays. By the combined use of large libraries of synthetic peptides and of substitution and truncation analogues, a putative DQ3.1 motif was defined. Its most prominent feature is the requirement for two small and/or hydrophobic residues spaced at positions i + 2 and i + 4. This motif is quite different from the motif recognized by DR molecules, but similar to the motif previously defined for certain IA alleles (the putative mouse homologue of DQ). These data suggest that various class II isotypes have evolved to present different peptide structures to each other, thus maximizing the repertoire of different epitopes available to T cell scrutiny.


This article has been cited by other articles:


Home page
Brief BioinformHome page
J. C. Tong, T. W. Tan, and S. Ranganathan
Methods and protocols for prediction of immunogenic epitopes
Brief Bioinform, March 1, 2007; 8(2): 96 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. A. Doytchinova and D. R. Flower
In Silico Identification of Supertypes for Class II MHCs
J. Immunol., June 1, 2005; 174(11): 7085 - 7095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette
The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity
J. Immunol., November 1, 2002; 169(9): 5098 - 5108.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. I. Pearson, A. M. Gautam, I. C. Rulifson, R. S. Liblau, and H. O. McDevitt
A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11
PNAS, January 5, 1999; 96(1): 197 - 202.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.